Avaleht/Aktsiad/PLSE

PLSE

USD

Pulse Biosciences Inc Common Stock (DE)

$16.060-0.440 (-2.667%)

Reaalajas hind

Healthcare

Medical Instruments & Supplies

Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad

Ettevõtte fundamentaalnäitajad

Kauplemisstatistika

Turunäitajad

Avatud

$16.500

Kõrge

$16.770

Madal

$15.800

Maht

0.11M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

1.1B

Tööstusharu

Medical Instruments & Supplies

Riik

United States

Kauplemisstatistika

Keskmine maht

0.18M

Börs

NCM

Valuuta

USD

52 nädala vahemik

Madal $13.766Praegune $16.060Kõrge $25

Seotud uudised

24. okt 2025 · 11:00

BusinessWire

Pulse Biosciences Announces First Enrollment in the NANOCLAMP AF Study

First U.S. Surgical Treatments with PFA Clamp for Patients with Atrial Fibrillation During Concomitant Surgical Procedure Pulse Biosciences, Inc. (NASDAQ:PLSE), a company leveraging its novel nPulse™ technology

Vaata rohkem

Pulse Biosciences Announces First Enrollment in the NANOCLAMP AF Study

22. okt 2025 · 20:05

BusinessWire

Pulse Biosciences Schedules Third Quarter 2025 Business Updates and Financial Results Conference Call for November 5, 2025

Pulse Biosciences, Inc. (NASDAQ:PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced it

Vaata rohkem

Pulse Biosciences Schedules Third Quarter 2025 Business Updates and Financial Results Conference Call for November 5, 2025

10. okt 2025 · 11:00

BusinessWire

Pulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse™ Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting

Successfully treated atrial fibrillation (AF) in initial 30 patients with the nPulse™ Cardiac Surgical System Pulse Biosciences, Inc. (NASDAQ:PLSE), a company leveraging its novel nPulse™ technology

Vaata rohkem